Join to View Full Profile
Duke Cancer Center20 Duke Medicine CirDurham, NC 27710
Phone+1 919-613-5550
Dr. Grilley-Olson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Juneko Grilley-Olson is an oncologist in Durham, NC and is affiliated with Duke University. She received her medical degree from University of Wisconsin School of Medicine and Public Health and has been in practice 14 years. She specializes in sarcoma, and developmental therapeutics.
Education & Training
University of North Carolina HospitalsFellowship, Hematology and Medical Oncology, 2006 - 2009
Hennepin HealthcareResidency, Internal Medicine, 2003 - 2006
University of Wisconsin School of Medicine & Public HealthClass of 2003
Certifications & Licensure
NC State Medical License 2006 - 2026
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Everolimus Versus Placebo in Head and Neck Cancer Start of enrollment: 2010 Apr 01
- BKM120 for Patients With PI3K-activated Tumors Start of enrollment: 2013 Mar 29
- Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy Start of enrollment: 2013 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Utility of the Singapore recurrence nomogram in a US cohort with a higher proportion of borderline and malignant phyllodes tumours.Ellery H Reason, Samantha M Thomas, Jennifer K Plichta, Astrid M Botty van den Bruele, E Shelley Hwang
Journal of Clinical Pathology. 2025-10-17 - Management of Desmoid Tumors.Juneko E Grilley-Olson, Gina Sotolongo, William R Jeck, Charles Y Kim, Nicole Larrier
Current Oncology Reports. 2025-10-11 - Circulating Tumor DNA (ctDNA) is Reliably Detected in Patients with Metastatic Malignant Phyllodes Tumors, a Feasibility Study.Ellery H Reason, Michael D Aiduk, Amanda L Nash, Susan G R McDuff, Derrick Renner
Annals of Surgical Oncology. 2025-10-01
Press Mentions
Largest-Ever Precision Medicine Oncology Trial Ready for LaunchJune 1st, 2015
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
